Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case–control study of older men and women
暂无分享,去创建一个
P. Whincup | S. Ebrahim | S. Wannamethee | G. Lowe | A. Rumley | B. Jefferis | P. Welsh | P. Whincup | D. Lawlor | Debbie A. Lawlor | S. Ebrahim | Paul Welsh | S. Wannamethee | G. Lowe
[1] C. Stefanadis,et al. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. , 2009, Journal of the American College of Cardiology.
[2] J. Mair,et al. Lack of association of soluble CD40 ligand with the presence of acute myocardial infarction or ischemic stroke in the emergency department. , 2009, Clinical chemistry.
[3] M. Woodward,et al. Associations of plasma pro‐inflammatory cytokines, fibrinogen, viscosity and C‐reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study , 2008, British journal of haematology.
[4] Nader Rifai,et al. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. , 2008, European heart journal.
[5] Vilmundur Gudnason,et al. Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review , 2008, PLoS medicine.
[6] V. Fuster,et al. Soluble CD40 Ligand Predicts Ischemic Stroke and Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[7] C. Stefanadis,et al. Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes , 2007, European journal of clinical investigation.
[8] H. Katus,et al. Increased plasma concentrations of soluble CD40 ligand in acute coronary syndrome depend on in vitro platelet activation. , 2007, Clinical chemistry.
[9] G. Lip,et al. High-Sensitivity C-Reactive Protein and Soluble CD40 Ligand as Indices of Inflammation and Platelet Activation in 880 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors, Stroke Risk Stratification Schema, and Prognosis , 2007, Stroke.
[10] P. Libby,et al. Influence of pre-analytical and analytical factors on soluble CD40L measurements. , 2006, Clinical science.
[11] A. Siegbahn,et al. Soluble CD40L Levels Are Regulated by the −3459 A>G Polymorphism and Predict Myocardial Infarction and the Efficacy of Antithrombotic Treatment in Non-ST Elevation Acute Coronary Syndrome , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[12] C. Heeschen,et al. Influence of sample type and storage conditions on soluble CD40 ligand assessment. , 2006, Clinical chemistry.
[13] E. Lonn,et al. The relationship between soluble CD40 ligand levels and Framingham coronary heart disease risk score in healthy volunteers. , 2005, Atherosclerosis.
[14] P. Libby,et al. Associations Between Soluble CD40 Ligand, Atherosclerosis Risk Factors, and Subclinical Atherosclerosis: Results from the Dallas Heart Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[15] P. Whincup,et al. The British Regional Heart Study 1975-2004. , 2004, International journal of epidemiology.
[16] Jian Zhu,et al. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[17] Vilmundur Gudnason,et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.
[18] Peter H. Whincup,et al. Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[19] L. Horstman,et al. Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. , 2004, Thrombosis research.
[20] S. Verma,et al. Biomarkers of Vascular Disease Linking Inflammation to Endothelial Activation: Part II , 2003, Circulation.
[21] S. Verma,et al. New Markers of Inflammation and Endothelial Cell Activation: Part I , 2003, Circulation.
[22] P. Libby,et al. Soluble CD40L: Risk Prediction After Acute Coronary Syndromes , 2003, Circulation.
[23] W. Daniel,et al. Upregulation of CD40-CD40 Ligand (CD154) in Patients With Acute Cerebral Ischemia , 2003, Stroke.
[24] C. Heeschen,et al. Soluble CD40 ligand in acute coronary syndromes. , 2003, New England Journal of Medicine.
[25] D. Lawlor,et al. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study , 2003, Journal of epidemiology and community health.
[26] F. Lampe,et al. Non-attendance at re-examination 20 years after screening in the British Regional Heart Study. , 2002, Journal of public health medicine.
[27] P. Whincup,et al. Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men , 2002, Circulation.
[28] P. Libby,et al. Soluble CD40L and Cardiovascular Risk in Women , 2001, Circulation.
[29] J. Danesh,et al. Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.
[30] K. Forfang,et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. , 1999, Circulation.
[31] T. Pietrucha,et al. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood-various anticoagulants are not equal. , 1996, Thrombosis research.
[32] B Rosner,et al. Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. , 1992, American journal of epidemiology.
[33] HYPERTENSION and coronary heart disease: classification and criteria for epidemiological studies. , 1959, World Health Organization technical report series.